Abstract
Purpose of review: The mortality of type 2 diabetic patients with renal disease is high during both the pre-dialysis period as well as the period under dialysis therapy. With respect to rare data in the literature it may be assumed that the mortality rate is especially high during the last year before and the first year after start of dialysis therapy. Recent findings: After reviewing the reports in the literature dealing with survival of diabetic patients with nephropathy it may be concluded that mortality is especially high during the year before and after initiating dialysis. There are exact survival data of type 2 diabetic patients under dialysis therapy but only few data concerning the survival during the last year prior to dialysis treatment. The possible reasons for this higher mortality shortly before and after start of dialysis are discussed in this article. Summary: The mortality in type 2 diabetic patients is especially high during the last year before and the first year after the start of dialysis therapy. However, only the higher mortality during the first year after initiating dialysis is well documented in the literature. Those patients who die early within 90 days of dialysis are not registered in the registries, therefore, the overall mortality during the first dialysis year is at least 5% higher than the registered. uring both periods several factors may play a causal role in the high mortality, a higher prevalence of heart failure, and a progression of macroangiopathy with higher incidence of cardiovascular events due to traditional and non-traditional risk factors, especially inflammation and oxidative stress.
Keywords: Type 2-diabetes, Renal failure, Mortality, Pre-dialysis period, Dialysis
Current Diabetes Reviews
Title: Highest Mortality During the Last Year Before and the First Year After Start of Dialysis Treatment in Type 2 Diabetic Patients with Nephropathy
Volume: 3 Issue: 2
Author(s): Georg Biesenbach
Affiliation:
Keywords: Type 2-diabetes, Renal failure, Mortality, Pre-dialysis period, Dialysis
Abstract: Purpose of review: The mortality of type 2 diabetic patients with renal disease is high during both the pre-dialysis period as well as the period under dialysis therapy. With respect to rare data in the literature it may be assumed that the mortality rate is especially high during the last year before and the first year after start of dialysis therapy. Recent findings: After reviewing the reports in the literature dealing with survival of diabetic patients with nephropathy it may be concluded that mortality is especially high during the year before and after initiating dialysis. There are exact survival data of type 2 diabetic patients under dialysis therapy but only few data concerning the survival during the last year prior to dialysis treatment. The possible reasons for this higher mortality shortly before and after start of dialysis are discussed in this article. Summary: The mortality in type 2 diabetic patients is especially high during the last year before and the first year after the start of dialysis therapy. However, only the higher mortality during the first year after initiating dialysis is well documented in the literature. Those patients who die early within 90 days of dialysis are not registered in the registries, therefore, the overall mortality during the first dialysis year is at least 5% higher than the registered. uring both periods several factors may play a causal role in the high mortality, a higher prevalence of heart failure, and a progression of macroangiopathy with higher incidence of cardiovascular events due to traditional and non-traditional risk factors, especially inflammation and oxidative stress.
Export Options
About this article
Cite this article as:
Biesenbach Georg, Highest Mortality During the Last Year Before and the First Year After Start of Dialysis Treatment in Type 2 Diabetic Patients with Nephropathy, Current Diabetes Reviews 2007; 3 (2) . https://dx.doi.org/10.2174/157339907780598234
DOI https://dx.doi.org/10.2174/157339907780598234 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blocking the Path to Death: Anti-Apoptotic Molecules in Ischemia /Reperfusion Injury of the Liver
Current Pharmaceutical Design Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
Current Cardiology Reviews Ubiquitin and ubiquitin-like proteins in cardiac disease and protection
Current Drug Targets Melatonin and Its Therapeutic Potential in Neuroprotection
Central Nervous System Agents in Medicinal Chemistry Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Osteoprotegerin and Diabetes-Associated Pathologies
Current Molecular Medicine Pulmonary Hemorrhage in Patients with Systemic Lupus Erythematosus
Current Respiratory Medicine Reviews Large Unrepaired Aortopulmonary Window Presenting in Adulthood
Current Cardiology Reviews Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology Selective Histone Deacetylase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Exercise Induced Cardioprotection: An Overview of a Unique Form of Preconditioning
Current Cardiology Reviews Surgical Ventricular Restoration: An Operation To Reverse Remodeling - The Basic Science (Part I)
Current Cardiology Reviews The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization
Current Pharmaceutical Design Piperine: Medicinal, Analytical and Therapeutics perspective
Current Bioactive Compounds Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Current Pharmaceutical Design The Role of Novel Biomarkers of Cardiovascular Disease in Chronic Kidney Disease: Focus on Adiponectin and Leptin
Current Cardiology Reviews Editorial [Hot Topic: Adrenomedullin in Hypertension and Beyond (Guest Editor: Johji Kato)]
Current Hypertension Reviews